Modeling and Simulation - PK/PD Archives | Page 17 of 44 | Certara

Publication

Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics

CertaraMarch 1, 2018

Publication

A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination with Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer

CertaraFebruary 27, 2018

Publication

Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation

CertaraFebruary 22, 2018

Publication

Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor

CertaraFebruary 15, 2018

Publication

Modeling and Simulation of Bone Mineral Density in Japanese Osteoporosis Patients Treated with Zoledronic Acid Using Tartrate-resistant Acid Phosphatase 5b, a Bone Resorption Marker

CertaraFebruary 8, 2018

Publication

Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial

CertaraJanuary 15, 2018

Publication

Model-informed Drug Development for Malaria Therapeutics

CertaraJanuary 6, 2018

On-Demand Webinar

How to Perform Level C IVIVC in Phoenix

Step-by-step guidance for Level C IVIVC studies.

CertaraDecember 13, 2017

Publication

Exposure-response of Veliparib to Inform Phase 2 Trial Design in Refractory or Relapsed Patients with Hematological Malignancies

CertaraNovember 1, 2017

Publication

A Distributed Delay Approach for Modeling Delayed Outcomes in Pharmacokinetics and Pharmacodynamics Studies

CertaraOctober 30, 2017

© 2026 Certara. All Rights Reserved. | Legal | Privacy policy